ECU Spring Break 2020 Pharma Conference
Pharmaceutical Development and Manufacturing Center of Excellence
2nd Annual ECU Spring Break 2020 Pharma Conference
March 10-11, 2020
Please Contact Jack Pender with questions, comments, or interest in the 2021 event
The 2020 Pharma Conference offered attendees a 2-day experience to participate in a choice of 18 topical discussions and lectures led by regional experts including Eastern Carolina ASQ members and special invited guests. The breakout sessions were related to the topics of quality, stability, and method development/validation. Attendees also shared information and networked with other pharma professionals.
Location and Information
Third floor, Science and Technology Building
East Carolina University
Beverages, lunch, snacks, digital lecture slides, and supplemental materials will be provided.
Related Documents & Speaker Bios
Abstracts for Sessions:
- General Sessions – Sponsored by Thermo Fisher Scientific
- Quality Sessions – Sponsored by ASQ Eastern Carolina 1126
- Stability Sessions – Sponsored by H&A Scientific
- Method Development and Validation Sessions – Sponsored by Waters
Geoff Carr was appointed as Manager, Analytical Development at Patheon Inc, Canada in 2000 and is now Director, Analytical Development, Thermofisher Patheon. Prior to that, he held positions of Manager, Analytical Sciences at Celltech-Chiroscience, UK, Head of Analytical Development at Medgenix, Belgium and before that at Wyeth Research, UK. He originally started his career in pharmaceutical analysis at The British Pharmacopoeia Laboratory where he held several posts and was finally appointed Head of the Laboratory. His academic background is a PhD in synthetic organic chemistry awarded by University of London, UK. He has been a Member of various British Pharmacopoeia Committees, a UK representative to Committees of the European Pharmacopoeia and Member of USP Committees and is currently a member of the 2015-2020 Cycle USP General Chapters – Physical Methods Expert Committee. He is the author of numerous papers, presentations at international conferences and workshops on various topics related to Pharmaceutical Analysis and particularly on the subject of Conducting Stability Studies.
Michael W. Dong
Dr. Michael W. Dong is a principal consultant in MWD Consulting, focusing on consulting and training services on HPLC, pharmaceutical analysis, and drug quality. He was formerly Senior Scientist in Analytical Chemistry and Quality Control at Genentech, Research Director at Synomics Pharma, Research Fellow at Purdue Pharma, and Senior Staff Scientist at Applied Biosystems/Perkin-Elmer. He holds a Ph.D. in Analytical Chemistry from the City University of New York and has 130+ publications, including a bestselling book on chromatography (HPLC and UHPLC for Practicing Scientists, 2nd Ed., Wiley, 2019). He is an advisory board member of LCGC magazine, American Pharmaceutical Review, and Chinese American Chromatography Association. He has been a columnist of “Perspectives of Modern HPLC” for LCGC North America since 2013.
Jane Weitzel has been working in analytical chemistry for over 40 years for pharmaceutical and mining companies. She is currently a consultant specializing in laboratory management systems, GMP testing, ISO/IEC 17025, an auditor, and an educator. Jane has applied Quality Systems and statistical techniques, including the evaluation and use of measurement uncertainty, in a wide variety of technical and scientific businesses. She has obtained the American Society for Quality Certification for both Quality Engineer and Quality Manager. Jane is a member of the USP’s Expert Committee on Statistics and a past member of the Expert Panel on Method Validation and Verification. For the 2010 – 2015 cycle, Jane was a member of the USP Reference Standards committee. In 2014 she was pointed to the Chinese National Drug Reference Standards Committee and attended their inaugural meeting in Beijing.
Registration is now closed but join us in 2021 for another amazing experience.